VMP 36565411000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Fluticasone propionate 250micrograms/dose dry powder inhaler
BNF code 0302000N0AAATAT
Virtual Therapeutic Moiety Fluticasone
Date identifier became valid 17 Jan 2019
Previous product identifier 320604001
Basis of preferred name INNM - International Non-proprietary Name (Modified)
Date of name applicability 1 Jan 2014
Previous name Fluticasone 250micrograms/dose dry powder inhaler
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units dose
Unit dose unit of measure dose
Virtual Product Ingredient
Ingredient Fluticasone propionate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 250.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit dose
Ontology Drug Form & Route
Form & Route powderinhalation.inhalation
Dose Form
Formulation Inhalation powder
Drug Route
Route Inhalation
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Flixotide 250micrograms/dose Accuhaler (CST Pharma Ltd)
Flixotide 250micrograms/dose Accuhaler (GlaxoSmithKline UK Ltd)
Flixotide 250micrograms/dose Accuhaler (Necessity Supplies Ltd)
Flixotide 250micrograms/dose Accuhaler (Sigma Pharmaceuticals Plc)
Virtual Medicinal Product Packs
Fluticasone propionate 250micrograms/dose dry powder inhaler 60 dose

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback